Top of this page
Skip navigation, go straight to the content

Newsroom Overview

Newsroom

Press Release

UCB announces approval of VIMPAT® in China02 Dec 2018

UCB announces approval of VIMPAT® in China

Read more
UCB and Amgen Announce FDA Advisory Committee Meeting to review EVENITY™ (Romosozumab) for the Treatment of Osteoporosis in Postmenopausal Women at High Risk for Fracture30 Nov 2018

UCB and Amgen Announce FDA Advisory Committee Meeting to review …

Read more
UCB presents latest research at 2018 American Epilepsy Society Annual Meeting demonstrating neurology commitment and leadership 30 Nov 2018

UCB presents latest research at 2018 American Epilepsy Society Annual …

Read more

UCB Stories

general picutre of neurology content 3 Dec 2018

Starting from a patient perspective focuses epilepsy treatment progress …

Read more
picture of green strategy 26 Nov 2018

Making our packaging ‘greener’

Read more
general picture of epilepsy 20 Nov 2018

UCB’s commitment to epilepsy

Read more

Social Media

 

Contact

The UCB media relations team responds to calls and emails from professional journalists only.